Monsanto Accused of Ghostwriting Papers on Roundup Cancer Risk

March 14, 2017, 7:54 PM UTC

Monsanto Co. was accused in court documents of ghostwriting scientific literature that led a U.S. regulator to conclude a key chemical in its Roundup weed killer shouldn’t be classified as carcinogenic.

Lawyers suing the company on behalf of farmers and others, who claim exposure to glyphosate caused their non-Hodgkin’s lymphoma, alleged in a court filing which was partially blacked out until March 14 that the Environmental Protection Agency “may be unaware of Monsanto’s deceptive authorship practice.”

The filing was made public by a federal judge in San Francisco handling the litigation. The judge said last month he’s inclined to require ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.